Loading... Please wait... Loading... Please wait...
ESTIMATED
05/14/2024
05/14/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$1.19 | -$1.19 | -$1.19 |
| Q2 2024 | 1 | -$1.51 | -$1.51 | -$1.51 |
| Q3 2024 | 3 | -$1.52 | $0.35 | -$0.70 |
| Q4 2024 | 1 | -$0.80 | -$0.80 | -$0.80 |
TRACON Pharmaceuticals, Inc. last posted its earnings results on Tuesday, May 14th, 2024. The company reported $-1.33 earnings per share for the quarter, missing analysts' consensus estimates of $-1.2 by $0.13. The company had revenue of 100,000 for the quarter and had revenue of 12.05 M for the year. TRACON Pharmaceuticals, Inc. has generated $0 earnings per share over the last year ($-0.11 diluted earnings per share) and currently has a price-to-earnings ratio of 1.46. TRACON Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/14/2024 | Q1 2024 | -$1.20 | -$1.33 | -0.13 | $100,000 | $100,000 | 03/05/2024 | Q4 2023 | -$0.60 | $0.01 | 0.61 | $1.50 M | $3.05 M | 11/09/2023 | Q3 2023 | -$0.06 | $0.29 | 0.35 | $0 | 08/14/2023 | Q2 2023 | -$0.36 | -$0.20 | 0.16 | $9.00 M | 05/10/2023 | Q1 2023 | -$0.29 | -$0.46 | -0.17 | $0 | 03/08/2023 | Q4 2022 | -$0.28 | -$0.32 | -0.04 | $0 | 11/14/2022 | Q3 2022 | -$0.30 | -$0.30 | 0 | $0 | 08/10/2022 | Q2 2022 | -$0.29 | -$0.31 | -0.02 | $0 | 05/11/2022 | Q1 2022 | -$0.41 | -$0.48 | -0.07 | $0 | 03/15/2022 | Q4 2021 | -$0.40 | -$0.40 | 0 | $100,000 | $0 | 11/03/2021 | Q3 2021 | -$0.32 | -$0.38 | -0.06 | $70,000 | $0 | 08/11/2021 | Q2 2021 | -$0.34 | -$0.58 | -0.24 | $251,867 | $346,000 | 05/05/2021 | Q1 2021 | -$0.32 | -$0.33 | -0.01 | $0 | 02/25/2021 | Q4 2020 | -$0.34 | -$0.28 | 0.06 | $0 | 11/10/2020 | Q3 2020 | -$0.61 | -$0.38 | 0.23 | $0 | 08/05/2020 | Q2 2020 | -$0.74 | -$0.70 | 0.04 | $0 | 05/13/2020 | Q1 2020 | -$0.99 | -$0.78 | 0.21 | $0 | 02/27/2020 | Q4 2019 | -$1.25 | $0 | 11/05/2019 | Q3 2019 | -$2.00 | -$1.74 | 0.26 | $0 | 08/07/2019 | Q2 2019 | -$1.90 | -$2.11 | -0.21 | $0 |
|---|
A. TRACON Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates.
A. The conference call for TRACON Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for TRACON Pharmaceuticals, Inc.'s latest earnings report can be read online.
A. TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) has a recorded annual revenue of $12.05 M.
A. TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) has a recorded net income of $12.05 M. TRACON Pharmaceuticals, Inc. has generated $-0.11 earnings per share over the last four quarters.
A. TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) has a price-to-earnings ratio of 1.46 and price/earnings-to-growth ratio is 0.02.
